How has been the historical performance of Biofil Chemicals?
Biofil Chemicals has shown fluctuating financial performance, with net sales declining to 33.40 Cr in March 2025 from 40.04 Cr in March 2024, while profits and earnings per share also decreased. Total assets increased to 50.96 Cr, but the company reported a net cash outflow of 2.00 Cr in March 2025.
Answer:The historical performance of Biofil Chemicals shows a fluctuating trend in its financial metrics over the years.Breakdown:
Biofil Chemicals reported net sales of 33.40 Cr in March 2025, a decline from 40.04 Cr in March 2024, but an increase from 30.04 Cr in March 2023. The total operating income mirrored this trend, reaching 33.40 Cr in March 2025. The company's total expenditure, excluding depreciation, was 32.55 Cr in March 2025, down from 39.22 Cr in March 2024. Operating profit (PBDIT) for March 2025 was 1.16 Cr, slightly lower than 1.31 Cr in March 2024. Profit before tax decreased to 0.74 Cr in March 2025 from 0.87 Cr in March 2024, while profit after tax was 0.56 Cr, down from 0.71 Cr in the previous year. The earnings per share (EPS) for March 2025 was 0.34, a decrease from 0.44 in March 2024. On the balance sheet, total assets increased to 50.96 Cr in March 2025 from 47.08 Cr in March 2024, with total liabilities also rising to 50.96 Cr. The company reported a net cash outflow of 2.00 Cr in March 2025, contrasting with a net cash inflow of 2.00 Cr in March 2024. Overall, Biofil Chemicals has experienced variability in its financial performance, with notable fluctuations in sales, profits, and cash flow.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
